Skip to content
Ubiquitin Ligase-ubiquitin-ligase.com
  • Home
  • About US
  • Search Search

Ubiquitin Ligase-ubiquitin-ligase.com

Post Categories Uncategorized
Post dateJanuary 13, 2025Post last updated dateUpdated January 13, 2025

Anti-IL-12 (IL-12a & IL-12b) Reference Antibody (briakinumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time55 sec read
Product Name : Anti-IL-12 (IL-12a & IL-12b) Reference Antibody (briakinumab)synonym : null,productDescription : Anti-IL-12...
Post Categories Uncategorized
Post dateJanuary 13, 2025Post last updated dateUpdated January 13, 2025

Anti-IL-10 Reference Antibody (BT-063)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time58 sec read
Product Name : Anti-IL-10 Reference Antibody (BT-063)synonym : null,productDescription : Anti-IL-10 Reference Antibody (BT-063)(CHA915)...
Post Categories Uncategorized
Post dateJanuary 12, 2025Post last updated dateUpdated January 12, 2025

Anti-FSH Mouse mAb

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time45 sec read
Product Name : Anti-FSH Mouse mAbsynonym : null,productDescription : NonemolecularWeight : 78endotoxin : Nonepurity...
Post Categories Uncategorized
Post dateJanuary 12, 2025Post last updated dateUpdated January 12, 2025

Anti-IGF-2 Reference Antibody (DX-2647)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time58 sec read
Product Name : Anti-IGF-2 Reference Antibody (DX-2647)synonym : null,productDescription : Anti-IGF2 Reference Antibody (DX-2647)(CHA914)...
Post Categories Uncategorized
Post dateJanuary 11, 2025Post last updated dateUpdated January 11, 2025

Anti-ERBB1 / EGFR / HER1 Reference Antibody (nimotuzumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-ERBB1 / EGFR / HER1 Reference Antibody (nimotuzumab)synonym : null,productDescription :...
Post Categories Uncategorized
Post dateJanuary 11, 2025Post last updated dateUpdated January 11, 2025

Anti-Mesothelin Reference Antibody (NIH patent anti-Mesothelin)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-Mesothelin Reference Antibody (NIH patent anti-Mesothelin)synonym : null,productDescription : Anti-Mesothelin Reference...
Post Categories Uncategorized
Post dateJanuary 10, 2025Post last updated dateUpdated January 10, 2025

Anti-IGF1R / CD221 Reference Antibody (ganitumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-IGF1R / CD221 Reference Antibody (ganitumab)synonym : null,productDescription : Anti-IGF1R /...
Post Categories Uncategorized
Post dateJanuary 10, 2025Post last updated dateUpdated January 10, 2025

Anti-IGF1R / CD221 Reference Antibody (figitumumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-IGF1R / CD221 Reference Antibody (figitumumab)synonym : null,productDescription : Anti-IGF1R /...
Post Categories Uncategorized
Post dateJanuary 9, 2025Post last updated dateUpdated January 9, 2025

Anti-TPBG Reference Antibody (naptumomAb)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-TPBG Reference Antibody (naptumomAb)synonym : null,productDescription : Anti-TPBG Reference Antibody (naptumomAb)(CHA908)...
Post Categories Uncategorized
Post dateJanuary 9, 2025Post last updated dateUpdated January 9, 2025

Anti-IgE Reference Antibody (talizumab)

Post author
Ubiquitin Ligase- ubiquitin-ligase
Post read time1 min read
Product Name : Anti-IgE Reference Antibody (talizumab)synonym : null,productDescription : Anti-IgE Reference Antibody (talizumab)(CHA904)...

Posts navigation

« 1 … 18 19 20 21 22 … 822 »

Recent Posts

  • phosphoribosyl pyrophosphate synthetase 1
  • anti-PD-1 antibody, NIH
  • protein phosphatase 1, regulatory subunit 15A
  • anti-NGF antibody, Sichuan University
  • phosphoribosyl pyrophosphate amidotransferase

Recent Comments

    Archives

    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Designed by Nasio Themes || Powered by WordPress